MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -41.04M | -15.42M | 56.31M | -55.66M | -52.19M |
Total Depreciation and Amortization | 1.77M | 2.05M | 1.84M | 1.81M | 1.84M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 4.60M | -27.67M | 6.13M | 6.34M | 4.86M |
Change in Net Operating Assets | -12.23M | 2.63M | -4.11M | 3.02M | -149.00K |
Cash from Operations | -46.89M | -38.41M | 60.16M | -44.49M | -45.64M |
Capital Expenditure | -529.00K | -620.00K | -592.00K | -1.04M | -1.46M |
Sale of Property, Plant, and Equipment | -- | 0.00 | 80.00K | 80.00K | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 10.43M | 42.09M | 36.11M | 48.39M | 26.25M |
Cash from Investing | 9.90M | 41.47M | 35.60M | 47.44M | 24.79M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | 159.00K | 6.00K | 631.00K | 2.64M |
Repurchase of Common Stock | -282.00K | -4.00K | -74.00K | -6.00K | -2.39M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -282.00K | 155.00K | -68.00K | 625.00K | 248.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -37.27M | 3.22M | 95.69M | 3.58M | -20.60M |